RGDA-DDI: Residual graph attention network and dual-attention based framework for drug-drug interaction prediction

Changjian Zhou, Xin Zhang, Jiafeng Li, Jia Song, Wensheng Xiang
8/27/2024
q-bio.MNcs.CEcs.LG

No official code found. Best implementation: HPC-NEAU/RGDA-DDI (3 stars, last commit 2024-06-19).

Abstract

Recent studies suggest that drug-drug interaction (DDI) prediction via computational approaches has significant importance for understanding the functions and co-prescriptions of multiple drugs. However, the existing silico DDI prediction methods either ignore the potential interactions among drug-drug pairs (DDPs), or fail to explicitly model and fuse the multi-scale drug feature representations for better prediction. In this study, we propose RGDA-DDI, a residual graph attention network (residual-GAT) and dual-attention based framework for drug-drug interaction prediction. A residual-GAT module is introduced to simultaneously learn multi-scale feature representations from drugs and DDPs. In addition, a dual-attention based feature fusion block is constructed to learn local joint interaction representations. A series of evaluation metrics demonstrate that the RGDA-DDI significantly improved DDI prediction performance on two public benchmark datasets, which provides a new insight into drug development.

View on arXivView PDF

Code Implementations(1)

HPC-NEAU/RGDA-DDICommunity100%
30PythonJun 19, 20242 years ago

Similar Papers

Cite this paper

@article{zhou2024rgdaddi,
  title  = {RGDA-DDI: Residual graph attention network and dual-attention based framework for drug-drug interaction prediction},
  author = {Changjian Zhou and Xin Zhang and Jiafeng Li and Jia Song and Wensheng Xiang},
  year   = {2024},
  eprint = {2408.15310},
  archivePrefix = {arXiv},
  url    = {http://arxiv.org/abs/2408.15310v1}
}

Add a badge to your README

Shows whether official code is linked for this paper.

Code of Paper badge
[![Code of Paper](https://codeofpaper.com/badge/2408.15310.svg)](https://codeofpaper.com/paper/2408.15310)

Discussion